Bridget Rigby

Tergus Pharma

Getting a promising new topical product from lab to patient is challenging. Making it all the way through the development pipeline will be time-consuming, risky, and unpredictable. That's why it makes sense to think ahead and partner with the topical experts that can give pharma companies like yours more opportunities for success, every step of the way. As a CDMO focused on topical dosage forms, Tergus has the proven ability to understand and anticipate the needs of our partners—even in the face of market changes, regulatory environments, or corporate strategy. Whether through our unrivaled expertise in R&D, providing clinical trial material manufacturing, and now the addition of full-scale commercial manufacturing, we are eager to support every aspect of your topical drug pipeline. Let's work together. Because getting there starts here.